Palatin Technologies Stock Price, News & Analysis (NYSEAMERICAN:PTN)

$0.84 -0.03 (-3.45 %)
(As of 12/15/2017 06:52 AM ET)
Previous Close$0.88
Today's Range$0.83 - $0.87
52-Week Range$0.29 - $1.05
Volume1.48 million shs
Average Volume1.95 million shs
Market Capitalization$166.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.67

About Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies logoPalatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company's primary product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD), which is a type of female sexual dysfunction (FSD) defined as low desire with associated distress. Its other drug development programs include Melanocortin receptor-4 (MC4r), PL-3994 and Melanocortin receptor-1 (MC1r). MC4r is a compound used for treatment of obesity and diabetes. PL-3994 is a subcutaneously injected guanylate-cyclase type A (GC-A) receptor agonist. MC1r agonist peptides are used for treatment of inflammatory and dermatologic disease indications.

Receive PTN News and Ratings via Email

Sign-up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorHealthcare
SymbolNYSEAMERICAN:PTN
CUSIPN/A
Phone+1-609-4952200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS$0.05
Net IncomeN/A
Net Margins39.28%
Return on EquityN/A
Return on Assets90.43%

Miscellaneous

EmployeesN/A
Outstanding Shares190,310,000

Palatin Technologies (NYSEAMERICAN:PTN) Frequently Asked Questions

What is Palatin Technologies' stock symbol?

Palatin Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "PTN."

How were Palatin Technologies' earnings last quarter?

Palatin Technologies, Inc. (NYSEAMERICAN:PTN) announced its quarterly earnings data on Monday, November, 13th. The biopharmaceutical company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by $0.01. The biopharmaceutical company had revenue of $26.94 million for the quarter, compared to the consensus estimate of $28 million. During the same period in the previous year, the company posted ($0.08) earnings per share. View Palatin Technologies' Earnings History.

Where is Palatin Technologies' stock going? Where will Palatin Technologies' stock price be in 2017?

2 equities research analysts have issued 12 month target prices for Palatin Technologies' shares. Their predictions range from $2.00 to $6.00. On average, they anticipate Palatin Technologies' share price to reach $4.00 in the next twelve months. View Analyst Ratings for Palatin Technologies.

Are investors shorting Palatin Technologies?

Palatin Technologies saw a increase in short interest in November. As of November 30th, there was short interest totalling 5,038,244 shares, an increase of 53.4% from the November 15th total of 3,283,577 shares. Based on an average daily volume of 2,833,586 shares, the days-to-cover ratio is currently 1.8 days. Approximately 2.8% of the company's stock are short sold.

Who are some of Palatin Technologies' key competitors?

Who are Palatin Technologies' key executives?

Palatin Technologies' management team includes the folowing people:

  • John K. A. Prendergast Ph.D., Chairman of the Board (Age 63)
  • Carl Spana Ph.D., President, Chief Executive Officer, Director (Age 53)
  • Stephen T. Wills CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary (Age 59)
  • Anthony M. Manning Ph.D., Director (Age 55)
  • Robert K. deVeer Jr., Independent Director (Age 70)
  • Alan William Dunton M.D., Independent Director (Age 61)
  • Zola P. Horovitz Ph.D., Independent Director (Age 80)
  • Joseph Stanley Hull, Independent Director (Age 64)

Who owns Palatin Technologies stock?

Palatin Technologies' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Russell Investments Group Ltd. (0.13%) and Bank of New York Mellon Corp (0.08%). View Institutional Ownership Trends for Palatin Technologies.

Who bought Palatin Technologies stock? Who is buying Palatin Technologies stock?

Palatin Technologies' stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Bank of New York Mellon Corp. View Insider Buying and Selling for Palatin Technologies.

How do I buy Palatin Technologies stock?

Shares of Palatin Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Palatin Technologies' stock price today?

One share of Palatin Technologies stock can currently be purchased for approximately $0.84.

How big of a company is Palatin Technologies?

Palatin Technologies has a market capitalization of $166.16 million.

How can I contact Palatin Technologies?

Palatin Technologies' mailing address is 4B Cedarbrook Dr, CRANBURY, NJ 08512-3641, United States. The biopharmaceutical company can be reached via phone at +1-609-4952200.


MarketBeat Community Rating for Palatin Technologies (PTN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  170 (Vote Outperform)
Underperform Votes:  103 (Vote Underperform)
Total Votes:  273
MarketBeat's community ratings are surveys of what our community members think about Palatin Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Palatin Technologies (NYSEAMERICAN:PTN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.85$2.85$2.68$2.68
Price Target Upside: 272.45% upside272.45% upside339.89% upside650.58% upside

Palatin Technologies (NYSEAMERICAN:PTN) Consensus Price Target History

Price Target History for Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies (NYSEAMERICAN:PTN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
11/13/2017Canaccord GenuitySet Price TargetBuy$6.00View Rating Details
10/29/2017Roth CapitalSet Price TargetBuy$2.00View Rating Details
9/22/2016S&P Equity ResearchLower Price Target$0.61 -> $0.55View Rating Details
(Data available from 12/15/2015 forward)

Earnings

Palatin Technologies (NYSEAMERICAN:PTN) Earnings History and Estimates Chart

Earnings by Quarter for Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies (NYSEAMERICAN PTN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2017Q1 18$0.06$0.05$28.00 million$26.94 millionViewN/AView Earnings Details
9/25/2017Q4 17($0.02)$0.07$18.54 million$33.90 millionViewN/AView Earnings Details
5/18/2017Q3 2017$0.10($0.02)$60.00 million$10.82 millionViewN/AView Earnings Details
2/9/2017Q2 2017($0.07)($0.06)ViewListenView Earnings Details
11/15/2016Q117($0.08)($0.08)ViewN/AView Earnings Details
9/20/2016Q416($0.08)($0.09)ViewListenView Earnings Details
5/17/2016Q316($0.08)($0.08)ViewN/AView Earnings Details
2/16/2016Q216($0.07)($0.08)ViewN/AView Earnings Details
11/12/2015Q116($0.08)($0.08)ViewListenView Earnings Details
9/21/2015Q415($0.06)($0.09)$2.05 million$12.95 millionViewListenView Earnings Details
5/13/2015Q315($0.04)($0.07)$0.41 millionViewListenView Earnings Details
2/13/2015Q115$0.01$0.03$5.40 million$4.90 millionViewN/AView Earnings Details
11/18/2014Q1 15$0.04$0.01$9.00 million$4.93 millionViewN/AView Earnings Details
9/9/2014Q4 14$0.03($0.04)ViewN/AView Earnings Details
5/13/2014Q3($0.03)($0.01)$500.00 millionViewListenView Earnings Details
11/14/2013Q1($0.05)($0.04)ViewListenView Earnings Details
10/1/2013Q413($0.05)($0.04)ViewListenView Earnings Details
5/14/2013Q3 2013($0.05)($0.04)$0.02 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Palatin Technologies (NYSEAMERICAN:PTN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Palatin Technologies (NYSEAMERICAN:PTN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Palatin Technologies (NYSEAMERICAN PTN) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Palatin Technologies (NYSEAMERICAN:PTN)
Institutional Ownership by Quarter for Palatin Technologies (NYSEAMERICAN:PTN)

Palatin Technologies (NYSEAMERICAN PTN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/4/2015Joseph Stanley HullDirectorBuy2,500$0.66$1,650.00View SEC Filing  
10/2/2015Robert K Deveer JrDirectorBuy10,000$0.82$8,200.00View SEC Filing  
2/26/2014Bvf Partners L P/IlMajor ShareholderSell540,181$1.14$615,806.34View SEC Filing  
2/19/2014Bvf Partners L P/IlMajor ShareholderSell305,966$1.17$357,980.22View SEC Filing  
3/19/2013Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
2/1/2013Alan W DuntonDirectorBuy2,000$0.59$1,180.00View SEC Filing  
1/28/2013Robert I TaberDirectorBuy5,000$0.59$2,950.00View SEC Filing  
12/31/2012Carl SpanaCEOBuy10,000$0.57$5,700.00View SEC Filing  
12/28/2012Stephen T WillsCFOBuy10,000$0.56$5,600.00View SEC Filing  
12/24/2012Perry B MolinoffDirectorBuy10,000$0.61$6,100.00View SEC Filing  
12/14/2012Robert K Deveer JrDirectorBuy21,960$0.70$15,372.00View SEC Filing  
9/4/2012Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Palatin Technologies (NYSEAMERICAN PTN) News Headlines

Source:

SEC Filings

Palatin Technologies (NYSEAMERICAN:PTN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Palatin Technologies (NYSEAMERICAN:PTN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Palatin Technologies (NYSEAMERICAN PTN) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.